Intuitive Surgical, Inc. $ISRG Shares Purchased by Fifth Third Bancorp

Fifth Third Bancorp grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 42.4% during the first quarter, Holdings Channel reports. The firm owned 307,602 shares of the medical equipment provider’s stock after acquiring an additional 91,566 shares during the quarter. Fifth Third Bancorp’s holdings in Intuitive Surgical were worth $141,801,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Riversedge Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after buying an additional 17 shares during the period. Fiduciary Financial Group LLC boosted its holdings in Intuitive Surgical by 2.1% during the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after acquiring an additional 19 shares during the period. Prosperity Consulting Group LLC grew its position in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after acquiring an additional 19 shares in the last quarter. Sunburst Financial Group LLC grew its position in Intuitive Surgical by 4.3% in the 4th quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 20 shares in the last quarter. Finally, WoodTrust Financial Corp increased its stake in Intuitive Surgical by 0.5% during the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after purchasing an additional 20 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $4.77 during trading hours on Friday, reaching $406.78. The stock had a trading volume of 1,858,933 shares, compared to its average volume of 2,319,796. Intuitive Surgical, Inc. has a 1 year low of $396.68 and a 1 year high of $603.88. The firm’s 50 day moving average is $422.09 and its 200-day moving average is $474.65. The stock has a market capitalization of $144.07 billion, a price-to-earnings ratio of 49.31, a P/E/G ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 in the last ninety days. Insiders own 0.60% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: BMO Capital Markets upgraded Intuitive Surgical to strong-buy, which can help sentiment by signaling confidence in the stock’s long-term outlook. Zacks.com
• Positive Sentiment: Investor interest remains supported by expectations that July 16 results will show higher sales and EPS, with strong adoption of the da Vinci 5 surgical robot seen as a key growth driver. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
• Neutral Sentiment: Evercore ISI cut its price target to $430 from $480 while keeping an In Line rating, suggesting the company still has growth potential but investors may be more cautious on near-term upside. Is Intuitive Surgical (ISRG) One Of MedTech’s Best AI Stock To Buy?
• Neutral Sentiment: Options traders are pricing in a wide range of outcomes for ISRG ahead of earnings, reflecting uncertainty around how the report and guidance could move the stock. Just How Much Risk Is Built Into ISRG Stock?
• Negative Sentiment: Investors are weighing possible margin pressure, which could limit enthusiasm even if revenue and earnings grow next quarter. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Raymond James Financial lowered their price objective on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. BTIG Research reaffirmed a “buy” rating and set a $574.00 target price on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Robert W. Baird increased their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $580.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $569.20.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.